Asymmetric Catalysis on Industrial Scale Challenges, Approaches and Solutions
by Blaser, Hans Ulrich; Federsel, Hans-Jü rgenBuy New
Rent Textbook
Used Textbook
We're Sorry
Sold Out
eTextbook
We're Sorry
Not Available
Summary
Author Biography
Hans-J?rgen Federsel is a renowned specialist in the field of process R&D with a professional career spanning over 30 years. Starting off as bench chemist in Astra at the major Swedish site in S?dert?lje, he climbed the ranks to occupy positions both as line and project manager. After the merger that formed AstraZeneca, he became Head of Projects Management at the aforementioned location and was then appointed to the newly created role as Director of Science in Global Process R&D in 2004. In connection with this, he was also given the prestigious title Senior Principal Scienstist. His strong academic links have been further developed over the years after obtaining the PhD in Organic Chemistry at the Royal Institute of Technology in Stockholm, which was led to his being awarded an Associate Professorship there.
His long-lasting links to this Institute has brought him a seat on the Board of the School of Chemical Science and Engineering from 2005. Publishing in peer reviewed journals and books and frequent lecturing has rendered fame to his name that goes far beyond the limits of the own company and Dr. Federsel enjoys invitations from all over the world to share learning and experience from his broad knowledge base on process R&D. In 2009 he was elected to the Royal Swedish Academy of Engineering Sciences (IVA).
Table of Contents
| Chemoenzymatic Route to the Side Chain of Rosuvastatin | |
| Application of Multiple Enzyme Systems for Chiral Alcohols Production | |
| Whole Microbial Cell Process for Manufacturing Amino Acids, Dipeptides and Oligosaccharides by Enzyme Catalysts Coupling with Cofactor Regeneration | |
| Biocatalytic Routes to the Large Scale Synthesis of Lotrafiban | |
| Asymmetric Oxidation for the Production of Bicyclic Proline Peptidomimetics | |
| Enzymatic C-C Bond Formation | |
| Large-Scale Applications of Hydrolases in Biocatalytic Asymmetric Synthesis | |
| Enzymatic Two Step Approach Towards a Chiral Intermediate on Pilot Scale for a Coagulation Factor Xa Inhibitor | |
| An Efficient, Asymmetric Synthesis of Odanacatib, a Selective Inhibitor of Cathepsin K for the Treatment of Osteoporosis, Using an Enzyme Mediated Dynamic Kinetic Resolution | |
| The Discovery and Implementation of a Novel Catalytic Asymmetric Conjugate Addition Reaction in the Synthesis of Endothelin A Antagonist ABT-546 | |
| Scale-Up Studies in Asymmetric Transfer Hydrogenation | |
| Ru-(Phosphine-Oxazoline) Complexes as Effective, Industrially Viable Catalysts for the Enantioselective Hydrogenation of Aryl Ketones | |
| Chiral Lactones by Asymmetric Hydrogenation - | |
| A Step Forward in (+)- Biotin Production | |
| The Asymmetric Hydrogenation of an Alpha-Isopropyl-Cinnamic Acid, an Intermediate for the Blood-Pressure Lowering Drug Aliskiren | |
| Commercialization of the Maruoka Catalyst | |
| Development of Efficient Technical Processes for the Production of Enantiopure Amino Alcohols in Pharmaceutical Industry | |
| The Kagan Oxidation - | |
| Industrial Scale Asymmetric Sulfoxidations in the Synthesis of Two Related NK1/NK2 Antagonists | |
| The Asymmetric Hydrogenation of Enones | |
| Large Scale Application of Asymmetric Phase Transfer Catalysis for Amino Acid Synthesis | |
| Crossing Over Hurdles in Large Scale Asymmetric Hydrogenation | |
| Application of Phase Transfer Catalysis in the Asymmetric Synthesis of an Estrogen Receptor Beta Selective Agonist | |
| Rh/Josiphos Catalyzed Ring Opening of Oxabicycles | |
| Hydrogenations on Multi kg Scale | |
| 2,2',5,5'-Tetramethyl-4,4'-bis(diphenylphosphino)-3,3'-bithiophene: A not well Known but very Efficient Chiral Ligand for Ru Catalyzed Asymmetric Hydrogenations on Multi-Kilos Scale | |
| 3+2 Addition Reaction and Diastereosel Reduction f Imine Both on Multi 10 kg Scale | |
| Enantioselective Hydrogenation: Applications in Process R&D of Pharmaceuticals | |
| Table of Contents provided by Publisher. All Rights Reserved. |
An electronic version of this book is available through VitalSource.
This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.
By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.
A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.
Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.
Please view the compatibility matrix prior to purchase.
